Paediatric Research Facility; The Children's Hospital at Uppsala University Hospital
Uppsala, Uppsala County, SE-751 85, Sweden
NCT Number: NCT02011217
The aim of this study is to contribute to a better understanding of how dietary fibre in rye affects appetite and metabolic processes. We will evaluate how the intake of rye crisp breads affects appetite, insulin secretion and glucose levels in the blood in healthy humans. We will also investigate microstructural properties of the crisp breads with microscopy, as well as to characterize the food products with respect to the content of dietary fibre and certain bioactive compounds. The aim is also to try to elucidate how observed effects on appetite are related to changes in insulin and glucose levels, appetite related hormonal signals and microstructural properties to verify findings from previous studies.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Uppsala, Uppsala County, SE-751 85, Sweden
The short-term effects (up to 4 hours after intake) of rye crisp breads on subjective appetite and metabolism will be evaluated using a randomized cross-over study design. Each participant will consume three different breakfasts consisting of two different rye crisp breads and one wheat crisp bread on three different occasions separated by a 1 week wash-out period. Participants will rate subjective appetite (satiety, hunger and desire to eat) by using a visual analogue scale (VAS) every 30 min during a 4-hour period, starting 30 min before breakfast. Blood samples will be collected before breakfast and at regular intervals throughout the day for analysis of glucose, insulin and hormone levels. Gastric emptying rate will also be evaluated using paracetamol as an indicator. Glucose and hormonal responses will be related to subjective appetite and to differences in composition of the breakfasts.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In a randomized cross-over design each subject receive one of three iso-caloric breakfasts on three different occasions, separated by 1 week wash-out period.
In a randomized cross-over design each subject receive one of three iso-caloric breakfasts on three different occasions, separated by 1 week wash-out period.
In a randomized cross-over design each subject receive one of three iso-caloric breakfasts on three different occasions, separated by 1 week wash-out period.
Time frame: -30, 0, 30, 60, 90, 120, 150, 180, 210, 240 minutes
Subjective feelings of appetite (satiety, hunger and desire to eat) assessed by visual analogue scale (VAS).
Time frame: -15, 15, 35, 65, 95, 125, 185, 230 minutes
Paracetamol (1 g) taken with breakfast. The appearance of paracetamol in the blood is directly related to the rate of gastric emptying.
Time frame: -15, 15, 35, 65, 95, 125, 185, 230 minutes
Glucagon, glucagon-like peptide-1 (GLP-1), glucose-dependent insulino-tropic polypeptide (GIP), peptide YY (PYY), cholecystokinin (CCK), leptin and ghrelin are measured in plasma samples.
Time frame: -15, 15, 35, 65, 95, 125, 185, 230 minutes
Glucose and insulin are measured in plasma samples.
Swedish University of Agricultural Sciences
Other
The Effects of Rye Crisp Bread on Subjective Appetite and Metabolic Function After Short-term Consumption
Acronym: S2RBAM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01965210
Appetite Regulation, Glucose Metabolism Disorders
Uppsala, Uppsala County, Sweden
View Trial DetailsNCT07079046
Appetite Regulation, Behavior
Valencia, Spain
View Trial DetailsNCT07491835
Appetite Regulation, Body Weight
London, United Kingdom
View Trial DetailsNCT07448519
Appetite Regulation, Body Weight
London, United Kingdom
View Trial Details